SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
BioCardia, Inc.
@BCDA_InsiderForm 4 Filing: Altman Peter Acquires (Grant) $132,750 of $BCDA
STOCK AWARD / GRANT
⚡ MATERIALITY: 4/10
corporate issuer
BioCardia, Inc.
Ticker: $BCDA
Transaction Value
$132,750
Price/Share: $1.20
transaction date
2026-06-29
Shares: 110,625
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Altman Peter, holds the title of President and CEO at BioCardia, Inc..
On 2026-06-29, the insider transacted 110,625 shares.The shares were transacted at a weighted average price of $1.20 per share, resulting in a total market-relevant value of $132,750.
Executive Summary Summary
Altman Peter (President and CEO) was granted $133K of $BCDA
Post-Transaction Position: 411,191 shares
SEC Accession No: 0001437749-26-022365 (CIK: 1647542)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.